336 related articles for article (PubMed ID: 28850704)
1. Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
Caocci G; Orofino MG; Vacca A; Piroddi A; Piras E; Addari MC; Caria R; Pilia MP; Origa R; Moi P; La Nasa G
Am J Hematol; 2017 Dec; 92(12):1303-1310. PubMed ID: 28850704
[TBL] [Abstract][Full Text] [Related]
2. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S
Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.
Bernardo ME; Piras E; Vacca A; Giorgiani G; Zecca M; Bertaina A; Pagliara D; Contoli B; Pinto RM; Caocci G; Mastronuzzi A; La Nasa G; Locatelli F
Blood; 2012 Jul; 120(2):473-6. PubMed ID: 22645178
[TBL] [Abstract][Full Text] [Related]
5. Second Hematopoietic Stem Cell Transplant for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan-Based Conditioning Regimen.
Korula A; Pn N; Devasia A; Lakshmi KM; Abraham A; Sindhuvi E; George B; Srivastava A; Mathews V
Biol Blood Marrow Transplant; 2018 Jan; 24(1):103-108. PubMed ID: 29032269
[TBL] [Abstract][Full Text] [Related]
6. Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.
Hussein AA; Al-Zaben A; Ghatasheh L; Natsheh A; Hammada T; Abdel-Rahman F; Abu-Jazar H; Sharma S; Najjar R; Frangoul H
Pediatr Blood Cancer; 2013 Aug; 60(8):1345-9. PubMed ID: 23424175
[TBL] [Abstract][Full Text] [Related]
7. French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
Galambrun C; Pondarré C; Bertrand Y; Loundou A; Bordigoni P; Frange P; Lutz P; Mialou V; Rubie H; Socié G; Schneider P; Bernaudin F; Paillard C; Michel G; Badens C; Thuret I; ;
Biol Blood Marrow Transplant; 2013 Jan; 19(1):62-8. PubMed ID: 22892550
[TBL] [Abstract][Full Text] [Related]
8. HLA-matched sibling stem cell transplantation in children with β-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience.
Goussetis E; Peristeri I; Kitra V; Vessalas G; Paisiou A; Theodosaki M; Petrakou E; Dimopoulou MN; Graphakos S
Bone Marrow Transplant; 2012 Aug; 47(8):1061-6. PubMed ID: 22080966
[TBL] [Abstract][Full Text] [Related]
9. Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression.
Meissner B; Lang P; Bader P; Hoenig M; Müller I; Meisel R; Greil J; Sauer MG; Metzler M; Corbacioglu S; Burkhardt B; Wölfl M; Strahm B; Kafa K; Basu O; Lode HN; Gruhn B; Cario H; Ozga AK; Zimmermann M; Jarisch A; Beier R
Bone Marrow Transplant; 2024 May; 59(5):587-596. PubMed ID: 38326567
[TBL] [Abstract][Full Text] [Related]
10. Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.
Lüftinger R; Zubarovskaya N; Galimard JE; Cseh A; Salzer E; Locatelli F; Algeri M; Yesilipek A; de la Fuente J; Isgrò A; Alseraihy A; Angelucci E; Smiers FJ; La La Nasa G; Zecca M; Fisgin T; Unal E; Kleinschmidt K; Peters C; Lankester A; Corbacioglu S;
Ann Hematol; 2022 Mar; 101(3):655-665. PubMed ID: 34999929
[TBL] [Abstract][Full Text] [Related]
11. Unrelated and related donor transplantation for beta-thalassemia major: A single-center experience from India.
John MJ; Mathew A; Philip CC; Singh S; Tanuja T; Kakkar N
Pediatr Transplant; 2018 Aug; 22(5):e13209. PubMed ID: 29726078
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab.
Sánchez LM; George A; Friend BD; Bhar S; Sasa G; Doherty EE; Craddock J; Steffin D; Salem B; Yassine K; Omer B; Martinez C; Leung K; Krance RA; John TD
Pediatr Hematol Oncol; 2024 May; 41(4):260-272. PubMed ID: 38131101
[TBL] [Abstract][Full Text] [Related]
13. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
[TBL] [Abstract][Full Text] [Related]
14. Augmented immunosuppression and PTCY-based haploidentical hematopoietic stem cell transplantation for thalassemia major.
Vellaichamy Swaminathan V; Ravichandran N; Ramanan KM; Meena SK; Varla H; Ramakrishnan B; Jayakumar I; Uppuluri R; Raj R
Pediatr Transplant; 2021 Mar; 25(2):e13893. PubMed ID: 33111490
[TBL] [Abstract][Full Text] [Related]
15. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
[TBL] [Abstract][Full Text] [Related]
16. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group.
Yesilipek MA; Ertem M; Cetin M; Öniz H; Kansoy S; Tanyeli A; Anak S; Kurekci E; Hazar V
Pediatr Transplant; 2012 Dec; 16(8):846-51. PubMed ID: 22931438
[TBL] [Abstract][Full Text] [Related]
17. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.
Anurathapan U; Hongeng S; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Charoenkwan P; Jetsrisuparb A; Sanpakit K; Rujkijyanont P; Meekaewkunchorn A; Lektrakul Y; Iamsirirak P; Surapolchai P; Satayasai W; Sirireung S; Sruamsiri R; Wahidiyat PA; Ungkanont A; Issaragrisil S; Andersson BS
Bone Marrow Transplant; 2016 Jun; 51(6):813-8. PubMed ID: 26878659
[TBL] [Abstract][Full Text] [Related]
19. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation.
Li C; Wu X; Feng X; He Y; Liu H; Pei F; Liao J; He L; Shi L; Li N; Liu Q; Liu S; Chen G; Su Q; Ren Y; Wang Y; Tan W
Blood; 2012 Nov; 120(19):3875-81. PubMed ID: 22968457
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China.
Li XY; Sun X; Chen J; Qin MQ; Luan Z; Zhu YP; Fang JP
World J Pediatr; 2018 Feb; 14(1):92-99. PubMed ID: 29511925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
